{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:21Z","timestamp":1789609101106,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T00:00:00Z","timestamp":1703289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtha.2023.12.020","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T02:53:40Z","timestamp":1703818420000},"page":"1046-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine"],"prefix":"10.1016","volume":"22","author":[{"given":"Marijn","family":"van der Neut Kolfschoten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Ingan\u00e4s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Perez-Peinado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Calado da Silva Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle M.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelie","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Przeradzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kourkouta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"van Manen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jort","family":"Vellinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Custers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinke","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.12.020_bib1","unstructured":"U.S. Food and Drug Administration. Janssen Ad26.COV2.S COVID-19 vaccine EUA review memorandum, Janssen Ad26.COV2.S COVID-19 vaccine_EUA Review Memorandum; June 15,\u00a02021."},{"key":"10.1016\/j.jtha.2023.12.020_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41541-020-00243-x","article-title":"Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 spike immunogen induces potent humoral and cellular immune responses","volume":"5","author":"Bos","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.jtha.2023.12.020_bib3","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.020_bib4","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.12.020_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.seminhematol.2022.02.002","article-title":"Epidemiology of VITT","volume":"59","author":"Pai","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2023.12.020_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/M21-4502","article-title":"Case series of thrombosis with thrombocytopenia syndrome after COVID-19 vaccination\u2014United States, December 2020 to August 2021","volume":"175","author":"See","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2023.12.020_bib7","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.15585\/mmwr.mm7032e4","article-title":"Use of COVID-19 vaccines after reports of adverse events among adult recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna): update from the Advisory Committee on Immunization Practices\u2014United States, July 2021","volume":"70","author":"Rosenblum","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jtha.2023.12.020_bib8","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.020_bib9","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.020_bib10","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1093\/eurheartj\/ehab506","article-title":"Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia","volume":"42","author":"Holm","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2023.12.020_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.020_bib12","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jth.15604","article-title":"Thrombosis and thrombocytopenia after HPV vaccination","volume":"20","author":"Johansen","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.020_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2036556","article-title":"VITT with inactivated SARS-CoV-2 vaccine \u2013 index case","volume":"18","author":"Devi","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jtha.2023.12.020_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12750","article-title":"Thrombotic thrombocytopenia after Sinopharm BBIBP-CorV COVID-19 vaccination","volume":"6","author":"Hosseinzadeh","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.020_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2021.10.002","article-title":"Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: a case study","volume":"208","author":"Rodr\u00edguez","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.12.020_bib16","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.7326\/L21-0244","article-title":"Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine","volume":"174","author":"Sangli","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2023.12.020_bib17","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3324\/haematol.2021.279075","article-title":"Post-mortem findings in vaccine-induced thrombotic thombocytopenia","volume":"106","author":"Pomara","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.12.020_bib18","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jtha.2023.06.026","article-title":"Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia","volume":"21","author":"Huynh","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.020_bib19","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1001\/jama.2021.9889","article-title":"Frequency of thrombocytopenia and platelet factor 4\/heparin antibodies in patients with cerebral venous sinus thrombosis prior to the COVID-19 pandemic","volume":"326","author":"S\u00e1nchez van Kammen","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.12.020_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1053\/j.seminhematol.2022.02.001","article-title":"Clinical picture of VITT","volume":"59","author":"Chen","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2023.12.020_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14945","article-title":"Anti-platelet factor 4\/polyanion antibodies mediate a new mechanism of autoimmunity","volume":"8","author":"Nguyen","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2023.12.020_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jtha.2023.12.020_bib24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3324\/haematol.2021.280154","article-title":"Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines","volume":"107","author":"Michalik","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.12.020_bib25","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/acs.jpcb.9b11695","article-title":"Physicochemical characteristics of platelet factor 4 under various conditions are relevant for heparin-induced thrombocytopenia testing","volume":"124","author":"Bui","year":"2020","journal-title":"J\u00a0Phys Chem B"},{"key":"10.1016\/j.jtha.2023.12.020_bib26","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1182\/blood.2022017696","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"141","author":"Cines","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.020_bib27","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood-2013-01-478966","article-title":"Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4","volume":"122","author":"Jaax","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.020_bib28","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41431-018-0132-4","article-title":"Circulating cell-free nucleic acids: characteristics and applications","volume":"26","author":"P\u00f6s","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jtha.2023.12.020_bib29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2023.12.020_bib30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/bloodadvances.2022007336","article-title":"Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S","volume":"7","author":"Huynh","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.12.020_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/blood.2021014588","article-title":"Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT","volume":"140","author":"Kanack","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.020_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ajh.26488","article-title":"Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies","volume":"97","author":"Kanack","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.12.020_bib33","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.2022016474","article-title":"Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody","volume":"140","author":"Wang","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.020_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1056\/NEJMc2206601","article-title":"SARS-CoV-2 infection in patients with a history of VITT","volume":"387","author":"Sch\u00f6nborn","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.12.020_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc2118507","article-title":"VITT and second doses of Covid-19 vaccine","volume":"386","author":"Lacy","year":"2022","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T10:32:46Z","timestamp":1711103566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623009224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1538783623009224"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.020","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}